Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2006.00666.x ◽

2007 ◽

Vol 9 (6) ◽

pp. 853-858 ◽

Author(s):

O. Schnell ◽

G. Mertes ◽

E. Standl ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Metabolic Control

Download Full-text

“Position Paper” Timely Insulinisation in Type 2 Diabetes Patients

Romanian Journal of Diabetes Nutrition and Metabolic Diseases ◽

10.2478/v10255-012-0051-z ◽

2012 ◽

Vol 19 (4) ◽

pp. 441-444

Author(s):

László Barkai ◽

Nicolae Hâncu ◽

György Jermendy ◽

Maya Konstantinova ◽

Radu Lichiardopol ◽

...

Keyword(s):

Quality Of Life ◽

Type 2 Diabetes ◽

Life Expectancy ◽

Insulin Therapy ◽

Metabolic Control ◽

Current Medical ◽

Position Paper ◽

Medical Evidence

AbstractThe objective of this position paper is to review the current medical evidence andguidelines regarding the treatment of type 2 diabetes (T2DM) and to issue medicalrecommendations strengthening the timely use of insulin in patients with T2DMuncontrolled on noninsulin therapy. When noninsulin therapy fails to achieve or tomaintain HbA1c targets, insulin therapy is required. Timely insulin therapy couldprovide proper metabolic control that might prevent complications, lead toimprovement of life expectancy and quality of life.

Download Full-text

Metabolic control and hypoglycaemia in people with type 2 diabetes on conventional or intensified insulin therapy: a 22 year retrospective single centre survey

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2783 ◽

2016 ◽

Vol 32 (6) ◽

pp. 652-658 ◽

Author(s):

G. Kramer ◽

N. Kuniss ◽

C. Kloos ◽

T. Lehmann ◽

N. Müller ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Metabolic Control ◽

Single Centre ◽

Intensified Insulin Therapy

Download Full-text

People with Type 2 Diabetes on Premixed Insulin Therapy: How is the Daily Insulin Dose Partitioned and are there Effects on the Metabolic Control?

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0035-1548796 ◽

2015 ◽

Vol 123 (06) ◽

pp. 368-370

Author(s):

J. Roth ◽

B. Milke ◽

N. Müller ◽

U. Zitterbart ◽

S. Rechtacek ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Metabolic Control ◽

Insulin Dose ◽

Premixed Insulin ◽

Daily Insulin ◽

Daily Insulin Dose

Download Full-text

Flexible Intensive Versus Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes: An open-label, randomized, controlled, crossover clinical trial of metabolic control and patient preference

Diabetes Care ◽

10.2337/dc07-0397 ◽

2007 ◽

Vol 30 (12) ◽

pp. 3031-3032 ◽

Author(s):

C. Kloos ◽

A. Samann ◽

T. Lehmann ◽

A. Braun ◽

B. Heckmann ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Therapy ◽

Metabolic Control ◽

Patient Preference ◽

Conventional Insulin Therapy ◽

Randomized Controlled

Download Full-text

P-35 Study of metabolic control, body weight, body mass index and blood pressure in patients with Type 2 diabetes with insulin resistance with intensified insulin therapy

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(08)70809-x ◽

2008 ◽

Vol 79 ◽

pp. S68

Author(s):

Anil Kumar ◽

Reddy Iska

Keyword(s):

Insulin Resistance ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Body Mass Index ◽

Body Weight ◽

Insulin Therapy ◽

Metabolic Control ◽

Body Mass ◽

Download Full-text

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Current Pharmaceutical Design ◽

10.2174/1381612013397357 ◽

2001 ◽

Vol 7 (14) ◽

pp. 1353-1373 ◽

Author(s):

C. Weyer ◽

D. Maggs ◽

A. Young ◽

O. Kolterman

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Metabolic Control ◽

Physiological Approach

Download Full-text

Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus

Patient Education and Counseling ◽

10.1016/j.pec.2008.05.005 ◽

2008 ◽

Vol 73 (1) ◽

pp. 50-59 ◽

Author(s):

Anke Braun ◽

Alexander Sämann ◽

Thomas Kubiak ◽

Tania Zieschang ◽

Christof Kloos ◽

...

Keyword(s):

Quality Of Life ◽

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Patient Education ◽

Insulin Therapy ◽

Metabolic Control ◽

Control Patient

Download Full-text

Should insulin therapy be started earlier in type 2 diabetes?

Internal Medicine News ◽

10.1016/s1097-8690(08)70555-9 ◽

2008 ◽

Vol 41 (10) ◽

pp. 8

Author(s):

MARTIN J. ABRAHAMSON ◽

BARRY J. GOLDSTEIN

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy

Download Full-text

Abstract #804945: Fasting and Postprandial Plasma Glucose Contribution to HBA1C in People with Type 2 Diabetes on Basalbolus Insulin Therapy: Results from a Meta-Analysis of Insulin Lispro Clinical Trials

Endocrine Practice ◽

10.1016/s1530-891x(20)39601-4 ◽

2020 ◽

Vol 26 ◽

pp. 114-115

Author(s):

Farai Chigutsa

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Insulin Therapy ◽

Plasma Glucose ◽

Insulin Lispro ◽

Meta Analysis ◽

Postprandial Plasma Glucose

Download Full-text

Efficacy and safety of Canagliflozin (CANA), an inhibitor of Sodium Glucose Co-Transporter 2 (SGLT2), added on to insulin therapy with or without oral agents in type 2 diabetes (T2D)

Diabetologie und Stoffwechsel ◽

10.1055/s-0033-1341911 ◽

2013 ◽

Vol 8 (S 01) ◽

Author(s):

D Matthews ◽

G Fulcher ◽

V Perkovic ◽

D de Zeeuw ◽

KW Mahaffey ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Efficacy And Safety ◽

Download Full-text